Hong Kong clears way for pre-revenue biotech IPOs, plans to accept listing applications by May
A much anticipated rule change in Hong Kong’s stock exchange will take effect at the end of this month, marking a new era where qualified …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
